L. Coria

发表

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins

S. Oliveira, M. Delpino, C. A. Fossati, 2013, PloS one.

Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report.

J. Vega, A. Ceballos, J. Geffner, 2023, medRxiv.

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

D. Comerci, Francisco Guaimas, J. Cassataro, 2019, Front. Immunol..

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Francisco Guaimas, J. Cassataro, Karina A. Pasquevich, 2019, Journal of controlled release : official journal of the Controlled Release Society.

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

S. McSorley, G. Briones, Seung‐Joo Lee, 2017, Front. Immunol..

A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.

F. Frank, G. Briones, F. Goldbaum, 2015, Journal of controlled release : official journal of the Controlled Release Society.

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis

Fernanda S. Oliveira, J. Borkowski, S. Oliveira, 2010, The Journal of Immunology.

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice

Fernanda S. Oliveira, S. Oliveira, H. Warzecha, 2011, PloS one.

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

S. Estein, C. A. Fossati, G. Giambartolomei, 2008, Infection and Immunity.

Brucella abortus induces apoptosis of human T lymphocytes.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2012, Microbes and infection.

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice

D. Alvarez, Julieta Alcain, J. Cassataro, 2022, Frontiers in Immunology.

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection

Lucía B. Chemes, D. Alvarez, Julieta Alcain, 2021, bioRxiv.

Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases

M. Delpino, P. Baldi, G. Giambartolomei, 2013, Journal of Neuroinflammation.

Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2011, Microbes and infection.

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.

F. Paolicchi, F. Goldbaum, S. Estein, 2009, Vaccine.

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

Lucía B. Chemes, Rodolfo M. Rasia, J. Cassataro, 2022, Computational and structural biotechnology journal.

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

J. Cassataro, Karina A. Pasquevich, Lorena M. Coria, 2020, Vaccine.

Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells

I. Frahm, M. Tkach, W. Béguelin, 2012, The Journal of Immunology.

T Cells + and CD4 Cells Breast Cancer Growth Mediated by NK Therapeutic Immune Responses against Cells and Elicits Prophylactic and Targeting Stat3 Induces Senescence in Tumor

I. Frahm, M. Tkach, W. Béguelin, 2012 .

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

M. Tkach, R. Schillaci, A. Trevani, 2016, The Journal of Immunology.

Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.

F. Frank, G. Giambartolomei, J. Cassataro, 2016, Vaccine.

This information is current as T Cells + and CD 4 CellsBreast Cancer Growth Mediated by NK Therapeutic Immune Responses against Cells and Elicits Prophylactic and Targeting Stat 3 Induces Senescence in Tumor

I. Frahm, M. Tkach, W. Béguelin, 2012 .